Dr. Reddy's Laboratories
RDY
#1725
Rank
NZ$22.27 B
Marketcap
NZ$26.72
Share price
-0.27%
Change (1 day)
8.67%
Change (1 year)

EPS for Dr. Reddy's Laboratories (RDY)

EPS in 2026 (TTM): NZ$0.63

According to Dr. Reddy's Laboratories's latest financial reports the company's current EPS (TTM) is NZ$0.66. In 2025 the company made an earnings per share (EPS) of NZ$1.42 an increase over its 2024 EPS that were of NZ$1.13.

EPS history for Dr. Reddy's Laboratories from 2012 to 2026

Annual EPS

Year EPS Change
2026 (TTM)NZ$0.63-55.28%
2025NZ$1.4225%
2024NZ$1.135.92%
2023NZ$1.078.45%
2022NZ$0.9918.06%
2021NZ$0.8434.06%
2020NZ$0.6221.94%
2019NZ$0.51-7.46%
2018NZ$0.5564.17%
2017NZ$0.347.49%
2016NZ$0.31-61.3%
2015NZ$0.816.44%
2014NZ$0.76-5.65%
2013NZ$0.8037%
2012NZ$0.59

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Novartis
NVS
NZ$9.54 1,349.99%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
NZ$1.29 96.09%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
NZ$3.60 447.00%๐Ÿ‡ซ๐Ÿ‡ท France
GSK plc
GSK
NZ$5.23 694.69%๐Ÿ‡ฌ๐Ÿ‡ง UK
Teva Pharmaceutical Industries
TEVA
NZ$0.82 24.28%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel